A comparative review of the isotretinoin pregnancy risk management programs across four continents

@article{Kovitwanichkanont2018ACR,
  title={A comparative review of the isotretinoin pregnancy risk management programs across four continents},
  author={Tom Kovitwanichkanont and Tim R Driscoll},
  journal={International Journal of Dermatology},
  year={2018},
  volume={57}
}
Isotretinoin has revolutionized the treatment of severe acne vulgaris, a condition which if left untreated may result in significant socio‐psychological implications for those affected. Timely access to isotretinoin therapy is important to avoid the risks of potential physical and emotional scarring. However, due to its high risks of teratogenicity, isotretinoin must be used with care in females of childbearing potential. Since isotretinoin's introduction, numerous risk management programs have… 
Non-compliance with pregnancy prevention recommendations for isotretinoin in Korea between 2019–2020
TLDR
The proportion of patients exposed to isotretinoin did not change, and there was no significant change in compliance, with the implementation of the RMP during the study period.
Isotretinoin: Communication for Preventing Birth Defects and Alerting of an Uncertain Risk of Suicide
This chapter discusses the succession of pregnancy prevention programmes (PPPs) for isotretinoin, a medicine effective against acne, but with high risks for birth defects and developmental disorders
Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience
TLDR
This article provides a commentary on 4 key areas: the use of oral isotretinoin vs oral antibiotics, including the importance of early recognition of nonresponse to treatment, the psychological effects of acne and isot retinointreatment, the side effects of isotretinosin therapy, and cosmetic treatment options that can help alleviate predictable side effects.
Isotretinoin: Still the cause of anxiety for teratogenicity
TLDR
The results of the present study showed that women became pregnant during isotretinoin intake and opted for pregnancy termination, and attention should be paid to the risk management programs mandating effective contraceptions, in order to lessen the drug‐related terminations.
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015
TLDR
Fetal exposure to acne treatments varied according to levels of teratogenicity, with reduced rates among users of isotretinoin and to a lesser extent doxycycline/minocycline.
Isotretinoin for acne vulgaris - an update on adverse effects and laboratory monitoring.
TLDR
An update on the evidence surrounding the adverse effects of isotretinoin is provided, and practical strategies to prevent and manage these adverse effects are discussed.
An update on maternal medication‐related embryopathies
TLDR
A selected (non-exhaustive) list of the most commonly prescribed medications considered to be significant human teratogens is reviewed and recommendations for pre-conception and antenatal counselling are provided.
Isotretinoin and Risk of Cardiovascular Events in Adults with Acne: A Population-based Retrospective Cohort Study
TLDR
Among adult patients with acne, no association was found between exposure to isotretinoin and an increased risk of cardiovascular events, and Physicians should not be discouraged from prescribing isot retinoin out of concern for cardiovascular effects.
Prospects of acne vaccines targeting secreted virulence factors of Cutibacterium acnes
TLDR
The prospects of creating acne vaccines targeting secreted virulence factors of C. acnes including secretory Christie-Atkins-Munch-Peterson (CAMP) factor are provided to provide a novel gateway towards the therapeutic treatment of acne vulgaris.
CCID_A_234231 943..951
TLDR
A commentary on 4 key areas: the use of oral isotretinoin vs oral antibiotics, including the importance of early recognition of nonresponse to treatment, the psychological effects of acne and isot retinoin treatment, and cosmetic treatment options that can help alleviate predictable side effects are provided.
...
...

References

SHOWING 1-10 OF 48 REFERENCES
Terminations of pregnancy associated with isotretinoin use in New Zealand.
TLDR
It is revealed that there appears to have been more unintended pregnancies related to isotretinoin use than previously thought and Widening funding of isot retinoin will likely increase the absolute numbers of pregnancies but also has the potential to increase relative numbers.
Does the teratogenicity of isotretinoin outweigh its benefits?
TLDR
The expected benefit from isotretinoin therapy to the expected risk using quality-adjusted life years (QALYs) as a common basis for the comparison and the present value of the cost of teratogenicity per affected individual with birth defect is estimated.
Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review
TLDR
The isotretinoin PPP must be scrutinized to identify whether new measures should be taken or whether the failures in the implementation need to be corrected, and to take into account the definition of the ultimate goal of a PPP and the acceptable burden.
Women's experiences with isotretinoin risk reduction counseling.
TLDR
Since few clinicians provide women information on highly effective (ie, intrauterine or subdermal) contraceptives, the iPLEDGE program increases anxiety about isotretinoin more than it helps women feel protected from the teratogenic risks of isot retinoin.
SURVEY OF AUSTRALIAN ISOTRETINOIN PRESCRIBING
TLDR
Judging from the 85% of questionnaires which were returned, isotretinoin is an effective and welt‐tolerated drug for the treatment of severe nodulocystic acne and the number of pregnancies occurring during and after treatment.
A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
TLDR
The pregnancy rate among women receiving isotretinoin therapy was substantially lower than that in the general population and was compatible with the characteristics and behavior of the enrolled women.
Terminations of Pregnancy for Exposure to Oral Retinoids in South Australia, 1985–1993
TLDR
Extension of guidelines for prescription and more detailed counselling in relation to the use of contraception are recommended and doctors intending to recommend terminations obtain consent to discuss exposure with the dermatologists concerned, who may not be aware of the exposed pregnancy.
Epidemiology of isotretinoin exposure during pregnancy.
...
...